---
layout: post
title: "Ivax Pharmaceuticals, Inc.; Withdrawal of Approval of an Abbreviated New Drug Application for Chloramphenicol Capsules, 250 Milligrams"
date: 2026-02-05 18:59:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-16077
original_published: 2022-07-27 00:00:00 +0000
significance: 8.00
---

# Ivax Pharmaceuticals, Inc.; Withdrawal of Approval of an Abbreviated New Drug Application for Chloramphenicol Capsules, 250 Milligrams

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 27, 2022 00:00 UTC
**Document Number:** 2022-16077

## Summary

The Food and Drug Administration (FDA) is withdrawing the approval of abbreviated new drug application (ANDA) 062247 for chloramphenicol capsules, 250 milligrams (mg), held by Ivax Pharmaceuticals, Inc. (Ivax). Ivax requested withdrawal of this application and has waived its opportunity for a hearing.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/27/2022-16077/ivax-pharmaceuticals-inc-withdrawal-of-approval-of-an-abbreviated-new-drug-application-for)
- API: https://www.federalregister.gov/api/v1/documents/2022-16077

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
